The US Department of Health and Human Services (HHS) has announced plans to cancel $500m (£376m) in funding for mRNA vaccines in development to combat viruses causing diseases such as the flu and COVID-19.
The decision will impact 22 projects spearheaded by major pharmaceutical companies for vaccines against bird flu and other viruses, according to HHS.